Article
Serological assessment of PRO-C16 (type XVI collagen formation) reflects intestinal fibrostenotic strictures in patients with Crohn’s disease
2025-02-03
Abstract excerpt
<title>Abstract</title> <p>Background Fibrostenotic stricturing disease affects 30–50% of patients with Crohn’s disease (CD) leading to intestinal resection. Currently, there exists a great medical need to identify biomarkers related to fibrostenotic strictures for optimized patient management. Thus, we investigated PRO-C16 as a biomarker for intestinal fibrosis in patients with CD. Methods Human serum from two...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0d443b2e-ecf9-53f9-b49d-d0de8f12393f
- DOI
- 10.21203/rs.3.rs-5882259/v1
